GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Optipharm Co Ltd (XKRX:153710) » Definitions » Price-to-Funds-From-Operations

Optipharm Co (XKRX:153710) Price-to-Funds-From-Operations : (As of May. 31, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Optipharm Co Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Optipharm Co (XKRX:153710) Business Description

Traded in Other Exchanges
N/A
Address
6, 63 Osong, Hwaseong-eup, Heungduk-gu, Chungcheongbuk-do, Cheongju, KOR
Optipharm Co Ltd is engaged in developing cell therapy products through animal stem cells, developing high value-added protein drugs using bio-reactors, selecting antibiotic/antiviral components and developing products. Its diagnosis division includes human diagnosis and animal diagnosis that focuses on the development of molecular diagnostics for a variety of diseases.